Back
55
Also listed as
PGUCY
OTC
Day Range
$0.59
$0.61
52-Week Range
$0.59
$0.61
Volume
388,750
50D / 200D Avg
$0.61
/
$0.61
Prev Close
$0.61
Price History
Financial Trends
Peer Comparison
vs Industrials sector median (890 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 10.0 | 14.4 |
| P/B | 5.1 | 1.9 |
| ROE % | 45.2 | 11.3 |
| Net Margin % | 4.5 | 6.5 |
| Rev Growth 5Y % | 6.9 | 8.4 |
| D/E | 9.7 | 0.6 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$0.08
$0.08 – $0.08
|
2.2 B | 1 |
| FY2027 |
$0.09
$0.08 – $0.09
|
2.2 B | 1 |
| FY2026 |
$0.08
$0.07 – $0.08
|
2.1 B | 1 |
Key Takeaways
Revenue grew 6.94% annually over 5 years — modest growth
ROE of 45.16% indicates high profitability
Debt/Equity of 9.65 — high leverage
Generating 140.62M in free cash flow
P/E of 9.96 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 11.90%
Growth
Revenue Growth (5Y)
6.94%
Revenue (1Y)-4.96%
Earnings (1Y)1.01%
FCF Growth (3Y)5.04%
Quality
Return on Equity
45.16%
ROIC7.89%
Net Margin4.53%
Op. Margin9.92%
Safety
Debt / Equity
9.65
Current Ratio0.93
Interest Coverage3.39
Valuation
P/E Ratio
9.96
P/B Ratio5.10
EV/EBITDA7.99
Dividend Yield0.08%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4.96% | Revenue Growth (3Y) | 3.30% |
| Earnings Growth (1Y) | 1.01% | Earnings Growth (3Y) | 19.56% |
| Revenue Growth (5Y) | 6.94% | Earnings Growth (5Y) | 28.34% |
| Profitability | |||
| Revenue (TTM) | 1.99B | Net Income (TTM) | 89.97M |
| ROE | 45.16% | ROA | 3.28% |
| Gross Margin | 30.25% | Operating Margin | 9.92% |
| Net Margin | 4.53% | Free Cash Flow (TTM) | 140.62M |
| ROIC | 7.89% | FCF Growth (3Y) | 5.04% |
| Safety | |||
| Debt / Equity | 9.65 | Current Ratio | 0.93 |
| Interest Coverage | 3.39 | Dividend Yield | 0.08% |
| Valuation | |||
| P/E Ratio | 9.96 | P/B Ratio | 5.10 |
| P/S Ratio | 0.45 | PEG Ratio | 5.71 |
| EV/EBITDA | 7.99 | Dividend Yield | 0.08% |
| Market Cap | 896.39M | Enterprise Value | 1.57B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.99B | 2.09B | 1.86B | 1.87B | 1.52B |
| Net Income | 89.97M | 89.07M | 62.93M | 94.39M | 33.16M |
| EPS (Diluted) | 0.06 | 0.06 | 0.04 | 0.06 | 0.02 |
| Gross Profit | 600.87M | 756.27M | 641.34M | 639.88M | 509.32M |
| Operating Income | 196.95M | 225.99M | 194.07M | 235.96M | 165.87M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.75B | 2.43B | 1.99B | 2.13B | 1.73B |
| Total Liabilities | 2.53B | 2.17B | 1.84B | 1.98B | 1.66B |
| Shareholders' Equity | 175.74M | 222.71M | 154.52M | 148.63M | 77.20M |
| Total Debt | 1.70B | 1.12B | 1.09B | 1.14B | 896.40M |
| Cash & Equivalents | 1.02B | 551.28M | 248.80M | 315.65M | 250.80M |
| Current Assets | 1.49B | 1.05B | 690.88M | 900.51M | 643.01M |
| Current Liabilities | 1.60B | 1.06B | 720.36M | 857.32M | 689.85M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#106 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026